Lawyers who want to sue drug companies will be drooling over the news that the FDA has ?certified? a 2009 letter sent anonymously by FDA staff to President Obama describing ?systemic corruption and wrongdoing that permeates all levels of FDA.?
The FDA?s official recognition of the letter means that lawyers who want to use it to demonstrate that the FDA isn?t perfect won?t have to go through weeks of tedious discovery demands to find someone at the FDA who can officially say,?Yup, we sent that”
“FDA “Corruption Letter Authenticated: Lawyers, Start Your Engines!
That?s going to be a headache for drug companies who often defend their drugs in court by saying, ?Hey, the FDA said this product was fine and we did everything they asked ? so it?s not fair to hold us responsible.?
Plaintiffs? lawyers can now hold up the letter in court and argue that drug companies have been on notice that the FDA is riddled with politics, conflicts of interest and outright corruption, and is, as the letter says, ?fundamentally broken.?
The letter made headlines when it was sent last year to John Podesta of Obama?s transition team. Written by a group of scientists on FDA letter head ? but with their names blacked out for fear of retaliation ? the letter describes a nightmare of bungling and self-dealing among higher-ups at the drug safety agency. It begs Obama to step in and reform the shop:
? many other FDA managers who have failed to protect the American public, who have violated laws, rules, and regulations, who have suppressed or altered scientific or technological findings and conclusions, who have abused their power and authority, and who have engaged in illegal retaliation against those who speak out, have not been held accountable and remain in place.
The letter cites three dark chapters in FDA history:
Former chief Andrew von Eschenbach?s interference with the approval of a knee device.
The approval of a breast cancer detection device by director of the Office of Device Evaluation Donna-Bea Tillman even though all FDA experts voted against it, following a phone call from Connecticut congressman Christopher Shays.
And the approval by Daniel Schultz of a medical device that prevents tissue scarring against the unanimous opinion of his scientific staff.
According to Doug Kreis, who sues drug companies, ?Consumers have been given a slight fighting chance now against [the] ?FDA Defense,? based on this certification.?
Still unanswered: Who wrote the thing.
Image by Flickr user mlcastle, CC 2.0
Related:
John Stossel?s Plan to Abolish the FDA Should Be Laughed Out of Town
Why the Maalox Stomach-Bleeding Mixup Is the FDA?s Fault
FDA Has Only 2 Inspectors Watching Drug Factories in China
Tags: FDA, Federal Government, Government, Jim Edwards
Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University’s business and journalism schools. Follow him on Twitter or send him an email.
BNET User Analysis
Voice your 2centsWeb Buzz:
FDA Derides ?Conspiracy Theory? Over Provenge Delay
Pharmalot – 38 days 17 hours 46 minutes ago
The behind-the-scenes battle continues to rage between the FDA and a determined group of patients and investors who have agitated for nearly three years for the agency to approve the Provenge prostate cancer vaccine. Known as Care To Live, they are appealing a federal court decision denying them access to FDA documents pertaining to a series of…
Drug Safety: FDA Approval vs. Product Liability
Healthcare Economist – 21 days 17 hours 14 minutes ago
Before a drug can come to market, it must receive FDA approval. This involves 3 phases of testing with Phase I having 20-80 volunteers and Phase III often testing more than 1,000 people. Despite the FDA approval, patients can sue drug companies if they are injured by a drug. Patients can generally sue manufacturers under one of three…
Franken urges end to gay blood ban
The Minnesota Independent – 10 days 12 hours 39 minutes ago
Sen. Al Franken is among 16 senators calling on the Food and Drug Administration (FDA) to end the ban on blood donations by gay men. In a letter to FDA commissioner Margaret Hamburg on Thursday, the senators called the policy ?medically and scientifically unsound? and called out the double standard placed on gay men who
Boston Scientific Faces $5 Million-a-Day Paperwork Problem
WSJ Health Blog – 10 hours 15 minutes ago
Boston Scientific is back in the regulatory doghouse after the medical-device maker failed to report to the FDA changes in how it manufactures its line of implantable heart defibrillators The company has recalled the devices and halted further shipments until it resolves the reporting issue with the FDA. The business accounts for 15% of its…
FDA Issues Rare Quadruple Warning to Kidney Drug Maker; Next Up, Double-Secret Probation
BNET Pharma – 5 days 8 hours 22 minutes ago
It?s considered serious when the FDA sends one of its ?warning letters? to a drug company. The event can be used in litigation against the firm, or depress its stock. Companies generally comply quickly with the FDA?s rockets, which tend to outline one or two ways in which a company has pushed the envelope in its marketing. But Shire…
